Erratum: Associations of Dietary Intake with Cardiovascular Disease, Blood Pressure, and Lipid Profile in the Korean Population: a Systematic Review and Meta-Analysis :: JLA :: Journal of Lipid and Atherosclerosis Erratum: Associations of Dietary Intake with Cardiovascular Disease, Blood Pressure, and Lipid Profile in the Korean Population: a Systematic Review and Meta-Analysis > > 10.12997/jla.2020.9.3.474 Erratum Open Access J Lipid Atheroscler. 2020 Sep;9(3):474-475. English. Published (...) online Sep 21, 2020. Copyright © 2020 The Korean Society of Lipid and Atherosclerosis. Erratum: Associations of Dietary Intake with Cardiovascular Disease, Blood Pressure, and Lipid Profile in the Korean Population: a Systematic Review and Meta-Analysis Jeongseon Kim, 1 Tung Hoang, 1 So Young Boo, 2 Ji Myoung Kim, 3 Jeong-Hwa Choi, 4 Eun Joo Park, 5 Seungmin Lee, 6 Eunmi Park, 7 Ji Yeon Min, 8 In Seok Lee, 9 and So Young Youn 10 1 Department of Cancer Biomedical Science, National Cancer Center

in meta-analysis. Stat Med 2001;20:641–654. Baik I, Abbott RD, Curb JD, Shin C. Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc 2010;110:1018–1026. Cha D, Park Y. Association between dietary cholesterol and their food sources and risk for hypercholesterolemia: the 2012–2016 Korea national health and nutrition examination survey. Nutrients 2019;11:E846 Chae MJ, Jang JY, Park K. Association between dietary calcium intake and the risk of cardiovascular disease (...) with metabolic syndrome in Korean: analysis of the third Korea National Health and Nutrition Examination Survey (KNHANES III). J Korean Med Sci 2010;25:1473–1479. Lee H, Lee J, Hwang SS, Kim S, Chin HJ, Han JS, et al. Potassium intake and the prevalence of metabolic syndrome: the Korean National Health and Nutrition Examination Survey 2008–2010. PLoS One 2013;8:e55106 Lee HA, An H, Park H. Identification of dietary patterns related to metabolic diseases and their association with cardiovascular disease: from

robust for inclusion in this review. The study did not evaluate all-cause death and all CVD-related death. We are unable to draw any conclusions about the effects of periodontal therapy on secondary prevention of CVD.For primary prevention of cardiovascular disease (CVD) in people diagnosed with periodontitis and metabolic syndrome, very low-certainty evidence was inconclusive about the effects of scaling and root planning plus antibiotics compared to supragingival scaling. There is no reliable (...) Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis. There may be an association between periodontitis and cardiovascular disease (CVD); however, the evidence so far has been uncertain about whether periodontal therapy can help prevent CVD in people diagnosed with chronic periodontitis. This is the second update of a review originally published in 2014, and first updated in 2017. Although there is a new multidimensional staging

Association between ambient fine particulate pollution and hospital admissions for cause specific cardiovascular disease: time series study in 184 major Chinese cities. To estimate the risks of daily hospital admissions for cause specific major cardiovascular diseases associated with short term exposure to ambient fine particulate matter (aerodynamic diameter ≤2.5 μm; PM2.5) pollution in China.National time series study.184 major cities in China.8 834 533 hospital admissions for cardiovascular (...) specific associations between PM2.5 and cardiovascular admissions, and random effects meta-analysis used to combine the city specific estimates.Over the study period, a mean of 47 hospital admissions per day (standard deviation 74) occurred for cardiovascular disease, 26 (53) for ischaemic heart disease, one (five) for heart failure, two (four) for heart rhythm disturbances, 14 (28) for ischaemic stroke, and two (four) for haemorrhagic stroke. At the national average level, an increase of 10 μg/m3

Birth month, birth season, and overall and cardiovascular disease mortality in US women: prospective cohort study. To evaluate the associations between birth month, birth season, and overall and cardiovascular disease mortality, and to examine the role of familial and socioeconomic factors in these associations.Prospective cohort study.Nurses' Health Study, established in 1976, an ongoing prospective cohort study in the United States.Female registered nurses who reported information on date (...) of birth at study enrolment (n=116 911, 1976-2014, followed for 38 years).Birth month and astronomical birth season (based on solstices and equinoxes as boundaries of the season categories).Age and various multivariable adjusted hazard ratios and 95% confidence intervals for the association between birth months (using November as the reference), astronomical birth season (using autumn as the reference), and overall and cardiovascular disease specific mortality were assessed using Cox proportional

Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons. Population-scale evidence for the association between dynamic changes in metabolic syndrome (MetS) status and alterations in the risk for major adverse cardiovascular events (MACE) is lacking.To investigate whether recovery from or development of MetS in a population is associated with an altered risk for MACE.Nationwide cohort study.An

Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. To evaluate the associations between maternal diabetes diagnosed before or during pregnancy and early onset cardiovascular disease (CVD) in offspring during their first four decades of life.Population based cohort study.Danish national health registries.All 2 432 000 liveborn children without congenital heart disease in Denmark during 1977-2016 (...) . Follow-up began at birth and continued until first time diagnosis of CVD, death, emigration, or 31 December 2016, whichever came first.Pregestational diabetes, including type 1 diabetes (n=22 055) and type 2 diabetes (n=6537), and gestational diabetes (n=26 272).The primary outcome was early onset CVD (excluding congenital heart diseases) defined by hospital diagnosis. Associations between maternal diabetes and risks of early onset CVD in offspring were studied. Cox regression was used to assess

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis Lowering low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular risk irrespective of age, but the evidence is less strong for older patients.This prespecified analysis from ODYSSEY OUTCOMES compared the effect of alirocumab vs. placebo in 18 924 patients with recent acute coronary syndrome (ACS) according to age. We examined the effect of assigned (...) treatment on occurrence of the primary study outcome, a composite of coronary heart disease death, myocardial infarction, ischaemic stroke, or unstable angina requiring hospitalization [major adverse cardiovascular event (MACE)] and all-cause death. Relative risk reductions were consistent for patients ≥65 vs. <65 years for MACE [hazard ratio (HR) 0.78, 95% confidence interval (CI) 0.68-0.91 vs. 0.89, 0.80-1.00; Pinteraction = 0.19] and all-cause death [HR 0.77, 0.62-0.95 vs. 0.94, 0.77-1.15

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 June 2019 May (...) 2019 April 2019 March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association , MD, MSc, FAHA, Chair , MD, Vice Chair , PhD , MD, MPH, FAHA , MD , MD, MSc , MD , MS , MD, FAHA , MD, MS Matthew J. Feinstein

Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. Recent guidelines endorse using history of menopause before age 40 years to refine atherosclerotic cardiovascular disease risk assessments among middle-aged women. Robust data on cardiovascular disease risk in this population are lacking.To examine the development of cardiovascular diseases and cardiovascular risk factors in women with natural and surgical menopause before age 40 years.Cohort study (UK (...) , +5.57/1000 woman-years [95% CI, 2.41-8.73]; P < .001). For the primary outcome, natural and surgical premature menopause were associated with hazard ratios of 1.36 (95% CI, 1.19-1.56; P < .001) and 1.87 (95% CI, 1.36-2.58; P < .001), respectively, after adjustment for conventional cardiovascular disease risk factors and use of menopausal hormone therapy.Natural and surgical premature menopause (before age 40 years) were associated with a small but statistically significant increased risk

Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial. Additional treatment options are needed for patients who do not achieve sufficient reduction in low-density lipoprotein cholesterol (LDL-C) level with available lipid-lowering therapies.To assess the efficacy of bempedoic acid vs placebo in patients at high cardiovascular risk receiving (...) maximally tolerated lipid-lowering therapy.Phase 3, randomized, double-blind, placebo-controlled clinical trial conducted at 91 clinical sites in North America and Europe from November 2016 to September 2018, with a final date of follow-up of September 22, 2018. A total of 779 patients with atherosclerotic cardiovascular disease, heterozygous familial hypercholesterolemia, or both met randomization criteria, which included LDL-C level 70 mg/dL (1.8 mmol/L) or greater while receiving maximally tolerated

with cardiovascular disease ( for further information on cardiovascular disease conditions. can help healthcare professionals make decisions about how to improve local primary care. There is a pack with local , looking at coronary heart disease, diabetes, kidney disease and stroke. The profiles compare the subject that include information on the inpatient care of people with diabetes who are admitted to hospital for a range of footcare conditions. The profiles compare data from the subject Spending on care (...) Cardiovascular disease data and analysis: guide for health professionals Cardiovascular disease data and analysis: guide for health professionals - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November

Comparison of Frequency of Atherosclerotic Cardiovascular Disease Events Among Primary and Secondary Prevention Subgroups of the Systolic Blood Pressure Intervention Trial The Pooled Cohort Equation (PCE) predicts 10-year risk of first-time atherosclerotic cardiovascular disease (ASCVD) events and was incorporated in analyses of a primary and secondary prevention population in the Systolic Blood Pressure Intervention Trial (SPRINT). Whether PCE enhances risk prediction among secondary

Effects of exercise on endothelial progenitor cells in patients with cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials Redirecting

The Association between the Risk of Cardiovascular Disease and Androgen Deprivation Therapy in Patients with Prostate Cancer. A Meta-Analysis and systematic review. The Association between the Risk of Cardiovascular Disease and Androgen Deprivation Therapy in Patients with Prostate Cancer. A Meta-Analysis and systematic review. | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research (...) Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The Association between the Risk of Cardiovascular Disease and Androgen Deprivation Therapy in Patients with Prostate Cancer. A Meta-Analysis and systematic review. Zhen Liang, Jun Zhu, Xiaoxin Duo, Shangheng Shi, Yawei Xu

The Association between the Risk of Cardiovascular Disease and Androgen Deprivation Therapy in Patients with Prostate Cancer. A Meta-Analysis and systematic review. The Association between the Risk of Cardiovascular Disease and Androgen Deprivation Therapy in Patients with Prostate Cancer. A Meta-Analysis and systematic review. | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research (...) Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The Association between the Risk of Cardiovascular Disease and Androgen Deprivation Therapy in Patients with Prostate Cancer. A Meta-Analysis and systematic review. Zhen Liang, Jun Zhu, Xiaoxin Duo, Shangheng Shi, Yawei Xu

Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial Adding rivaroxaban to aspirin in patients with stable atherosclerotic disease reduces the recurrence of cardiovascular disease (CVD) but increases the risk of major bleeding. The aim of this study was to estimate the individual lifetime treatment benefit and harm of adding low-dose rivaroxaban to aspirin in patients with stable (...) cardiovascular disease.Patients with established CVD from the COMPASS trial (n = 27 390) and SMART prospective cohort study (n = 8139) were used. Using the pre-existing lifetime SMART-REACH model for recurrent CVD, and a newly developed Fine and Gray competing risk-adjusted lifetime model for major bleeding, individual treatment effects from adding low-dose rivaroxaban to aspirin in patients with stable CVD were estimated, expressed in terms of (i) life-years free of stroke or myocardial infarction (MI

Nov Oliver-Williams CT. et al. Published on: 2007 Jun 02 Wang X. et al. Use the article you are viewing now to seed an intelligent alerting service that pinpoints the most relevant new articles for you. chevron_left chevron_right Relevant Sections Public Health & Epidemiology Preventive Medicine Gastroenterology & Hepatology Clinical Nutrition Cardiovascular Disorders Coronary Artery Disease Vascular Diseases (Non-Coronary) Neurological Disorders Cerebrovascular Disease close Make sure you never (...) F1000Prime recommendation of The effect of folic acid in patients with cardiovascular disease: A systematic review and meta-analysis. The effect of folic acid in patients with... | Faculty Opinions On April 12th, 2020, F1000Prime became Faculty Opinions. See our to learn more. Welcome Guest 1 Recommendations info_outline Systematic Review / Meta-analysis Controversial +2 more close Classified As Controversial 1 Interesting Hypothesis 1 New Finding 1 Article Type Systematic Review / Meta

Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study. To investigate whether fenofibrate as add-on to statin treatment reduce persistent cardiovascular risk in adults with metabolic syndrome in a real world setting.Propensity matched cohort study.Population based cohort in Korea.29 771 adults with metabolic syndrome (≥40 years) receiving statin treatment. 2156 participants receiving combined treatment (statin plus fenofibrate (...) ) were weighted based on propensity score in a 1:5 ratio with 8549 participants using statin only treatment.Primary outcome was composite cardiovascular events including incident coronary heart disease, ischaemic stroke, and death from cardiovascular causes.The incidence rate per 1000 person years of composite cardiovascular events was 17.7 (95% confidence interval 14.4 to 21.8) in the combined treatment group and 22.0 (20.1 to 24.1) in the statin group. The risk of composite cardiovascular events

Nov Oliver-Williams CT. et al. Published on: 2007 Jun 02 Wang X. et al. Use the article you are viewing now to seed an intelligent alerting service that pinpoints the most relevant new articles for you. chevron_left chevron_right Relevant Sections Public Health & Epidemiology Preventive Medicine Gastroenterology & Hepatology Clinical Nutrition Cardiovascular Disorders Coronary Artery Disease Vascular Diseases (Non-Coronary) Neurological Disorders Cerebrovascular Disease close Make sure you never (...) F1000Prime recommendation of The effect of folic acid in patients with cardiovascular disease: A systematic review and meta-analysis. The effect of folic acid in patients with... | Faculty Opinions On April 12th, 2020, F1000Prime became Faculty Opinions. See our to learn more. Welcome Guest 1 Recommendations info_outline Systematic Review / Meta-analysis Controversial +2 more close Classified As Controversial 1 Interesting Hypothesis 1 New Finding 1 Article Type Systematic Review / Meta